WALTHAM, Massachusetts, May 21 /PRNewswire/ --
- ABSNet Loan Provides Performance Metrics on US Non-Agency MBS Transactions
Lewtan Technologies, Inc., provider of ABSNet, the industry's leading source for asset-backed securities surveillance data, analytics, software, and content for the global securitisation industry, today announced the unveiling of a new product called ABSNet Loan. ABSNet Loan provides valuable key performance metrics and predictive variables on the mortgages and home equity loans that back US non-agency MBS and home equity transactions.
LONDON, May 21 /PRNewswire/ -- It's time to move beyond the Lehman Sisters would have survived argument, which suggested that if women had been in charge, the banks would not have fallen into crisis in 2008, says Avivah Wittenberg-Cox, CEO of the consultancy 20-first, author and publisher of the new business website, http://www.WOMEN-omics.com.
Yes, women do have a right to be angry. The leadership teams of the banks that failed to judge the risks they were taking properly are dominated by men, she says.
But, she says, the most important question for all those concerned about the future robustness of the financial sector is what is the risk of not having a more equal gender balance on the top teams of the banks?
Pulsars are superdense neutron stars, the remnants left after massive stars have exploded as supernovae. Their powerful magnetic fields generate lighthouse-like beams of light and radio waves that sweep around as the star rotates. Most rotate a few to tens of times a second, slowing down over thousands of years.
The Mars rover, Opportunity, surveyed the rim and interior of Victoria Crater on the Red Planet from September 2006 through August 2008. Key findings from that work, reported in the May 22 edition of Science, reinforce and expand what researchers learned from Opportunity's exploration of two smaller craters after landing on Mars in 2004.
You're sitting in a room filled with a gazillion air molecules - how likely is it that most of those air molecules will spontaneously end up in the corner of the room opposite of where you're sitting?
Most likely you're not too concerned about this scenario, because something like that, a massive fluctuation in the distribution of air molecules in the room, is extremely unlikely, to put it mildly.
When you have zillions of air molecules bouncing around in a room (zillions here being on the order of 10^28 molecules of the various gases that make up air), the fluctuations away from the average distribution are miniscule.
BASEL, Switzerland, May 21 /PRNewswire/ --
**This press release is not intended for the UK media**
- Once daily QAB149 (indacaterol) significantly improves lung function compared to formoterol and tiotropium, two currently approved COPD treatments, at three months of treatment[1,2] - Pending approval, QAB149 could be the first once-daily bronchodilator to combine clinically relevant 24-hour bronchodilation with onset of action within five minutes[3,4,5] - All doses of QAB149 are well-tolerated with a good overall safety profile in three pivotal trials: INVOLVE (1 year), INHANCE (6 months) and INLIGHT-1 (3 months)[4,5,6] - COPD, a debilitating and progressive respiratory disease, is a leading and growing cause of death that affects 210 million people worldwide[7]
If you own a computer you have probably gotten a 'virus' but there have been no major outbreaks of mobile phone viral infection despite the fact that over 80 percent of Americans now use these devices. A team headed by Albert-Laszlo Barabasi, director of the Center for Complex Network Research at Northeastern University, set out to explain why this is true.
A class of drugs already approved as cancer treatments might also help to beat alcohol addiction. That's the conclusion of a discovery in flies of a gene, dubbed happyhour, that has an important and previously unknown role in controlling the insects' response to alcohol.
Animals with a mutant version of the gene grow increasingly resistant to alcohol's sedative effects, the research shows. The researchers report further evidence that the gene normally does its work by blocking the so-called Epidermal Growth Factor (EGF) pathway. That EGF pathway is best known for its role in cancer, and drugs designed to inhibit the EGF receptor, including erlotinib (trade name Tarceva) and gefitinib (trade name Iressa), are FDA-approved for the treatment of non-small cell lung cancer.
New research provides exciting genetic insight into a rare syndrome that first appeared in the medical literature in the mid 1800s with the case of Julia Pastrana, the world's most notorious bearded lady. The study, published by Cell Press in the May 21st issue of the American Journal of Human Genetics, reveals intriguing molecular clues about the pathogenesis of this mysterious condition that has captured the attention of the public since the Middle Ages.
Is there an advantage to being short? I think so, but I'm biased, being what the French call quite "petite." Good things come in small packages, I say.
But now at least one person with a presumably solid foundation in science backs me up. So when I hear yet another short joke (and I think I've heard 'em all), I can smile smugly to myself and know that all you leviathan, Brobdingnagian skyscrapers over 5' (or for the non-abnormal-American-measurementally inclined, 1.5 m) are actually at a disadvantage.
Later In Life
